| Financial Year |
March 31 2023 |
| Monetary Funds |
55,570,869,746.32 |
| Held-for-trading Financial Assets |
24,442,337.38 |
| Notes Receivable |
570,000.00 |
| Accounts Receivable |
1,434,018,404.07 |
| Advances to Suppliers |
4,379,117,930.80 |
| Other Receivables |
3,474,017,035.74 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
28,560,000.00 |
| Inventories |
259,255,146,534.80 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
26,077,075.02 |
| Other Current Assets |
53,836,419,193.49 |
| Total Current Assets |
378,008,282,616.56 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
84,856,499.77 |
| Long-term Equity Investment |
22,149,956,387.10 |
| Investment Properties |
16,772,997,054.94 |
| Fixed Assetes |
2,878,257,275.80 |
| Under-construction Projects |
599,104,731.94 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
495,488,356.24 |
| R&D expenses |
17,329,250.40 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
186,372,367.89 |
| Deferred Income Tax Assets |
4,465,458,441.87 |
| Other Non-Current Assets |
18,000,000.00 |
| Sub-Total of Non-Current Assets |
48,842,917,595.93 |
| Total Assets |
426,851,200,212.49 |
| Short-Term Loans |
914,815,238.13 |
| Trading Financial liabilities |
-- |
| Notes Payable |
557,083,738.95 |
| Accounts Payable |
31,026,504,763.23 |
| Accounts Received In Advance |
515,274,856.13 |
| Employee Compensation Payable |
174,766,000.99 |
| Taxes Payable |
826,422,300.87 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
26,359,343,424.35 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
26,278,386,037.85 |
| Other Current Liabilities |
10,372,526,150.64 |
| Sub-Total of Current Liabilities |
188,714,854,236.71 |
| Long-term Loans |
87,080,231,843.37 |
| Bonds Payable |
21,934,705,103.40 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
234,804,099.27 |
| Other Non-Current Liabilities |
17,188,621,653.06 |
| Sub-Total of Non-Current Liabilities |
127,369,249,679.80 |
| Total Liabilities |
316,084,103,916.51 |
| Paid-In Capital(Or Share Stock) |
2,117,161,116.00 |
| Capital Surplus |
141,900,365.12 |
| Surplus Reserve |
1,068,918,465.89 |
| LESS:Treasury Stock |
23,040.00 |
| Undistributed Profits |
14,374,153,141.10 |
| Minority Stockholder's Interest |
91,793,056,409.37 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
18,974,039,886.61 |
| Owner's Equity（Stockholder's Equity） |
110,767,096,295.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
426,851,200,212.49 |
